Investigating the Retardation Effect of OCTA-Guided Targeted Photocoagulation on the Progression of Non-Perfusion Areas in Diabetic Retinopathy Patients

Sichuan Provincial People's Hospital

Status: Not yet enrolling

Conditions: Diabetic Retinopathy

Treatments: Procedure: Targeted laser photocoagulation guided by OCTA (Optical Coherence Tomography Angiography)

Study type: Interventional

Funder types: Other

Identifiers

NCT06821633

2024-KY740-1

Details and patient eligibility

About

This study aims to evaluate the impact of widefield OCTA-guided selective photocoagulation on the progression of diabetic retinopathy (DR) by comparing the control of non-perfusion (NP) areas, DR grading, and management of other DR lesions. The study is designed as a parallel randomized controlled trial. From February 2025 to August 2026, 30 diabetic patients attending the Ophthalmology Department of Sichuan Provincial People's Hospital will be enrolled. Using a simple randomization method, one eye of each patient will be assigned to the intervention group, while the contralateral eye will serve as the control, resulting in 30 eyes in each group. The intervention group will undergo OCTA-guided selective photocoagulation, specifically using a grid pattern (3x3) of spot laser applied once to the NP area, extending one spot diameter beyond the NP boundary. Each session will last 10-20 minutes. The control group will receive no treatment. The study will compare changes in NP area, DR grading progression, and control of other DR lesions at 3, 6, 9, and 12 months between the two groups.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years
• Type 1 or Type 2 diabetes mellitus
• Clinical dilated fundus examination and Optos imaging within 7 fields showing diabetic retinopathy (DR) lesions no more severe than severe non-proliferative diabetic retinopathy (NPDR)
• Optical coherence tomography angiography (OCTA) demonstrating non-perfusion (NP) areas greater than 1 disc diameter (PD) in both eyes
• Diabetic retinopathy in both eyes at the same stage, with the total NP area within the observed range of OCTA being comparable (difference less than 5 PD)
• Absence of other ocular diseases that could lead to the formation of retinal microaneurysms
• Absence of other ocular diseases that could lead to the formation of retinal non-perfusion areas
• No diabetic macular edema involving the fovea
• No history of retinal laser treatment
• No history of intravitreal injection therapy within the past 3 months
• No history of ocular surgery other than cataract surgery
• Ability to cooperate with all examinations and provide informed consent

Exclusion criteria

• Optical media opacity affecting OCTA imaging
• Patients with difficulties in cooperating with laser treatment
• Patients with renal failure, diabetic neuropathy, or severe cardiovascular diseases
• Patients who are unlikely to complete follow-ups every 3 months, as well as those residing in other provinces
• Patients requiring early PRP (conditions include: combined DME, planned cataract surgery, pregnancy planning, early PDR, poor follow-up compliance, severe vision loss in the other eye, poor glycemic control, poor renal function, or type 1 diabetes)
• FFA showing NP greater than 10 PD within the ETDRS area or a total NP area greater than 75 PD, or an ischemia index greater than 35%

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

30 participants in 2 patient groups

Eyes with NPDR that were diagnosed and underwent TRP guided by OCTA at our hospital

Experimental group

Description:

The patient's eyes were first scanned using the Topcon OCTA (five-field montage) with a 24×20mm and a 6×6mm scan range. After enrollment, the patient underwent treatment on the same day in the retinal laser room. The laser treatment was performed by the same ophthalmologist. After obtaining baseline fundus images, the treating ophthalmologist overlaid the OCTA images onto the fundus images using retinal vessel alignment to guide targeted photocoagulation of the retinal non-perfusion (NP) areas under OCTA guidance. The specific photocoagulation method involved applying a grid pattern of spot laser (3×3) to the NP area once, with the treatment area extending beyond the NP boundary by one laser spot diameter. The total procedure duration was 10-20 minutes.

Treatment:

Procedure: Targeted laser photocoagulation guided by OCTA (Optical Coherence Tomography Angiography)

Eyes with NPDR that were diagnosed at our hospital

No Intervention group

Description:

Perform the same examination but administer no treatment